Victory Capital Management Inc Akero Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$95.8 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$11.38 - $50.33 $2.04 Million - $9.04 Million	-179,572 Reduced 92.83%	13,880 $324,000
Q3 2023 Nov 06, 2023	SELL	$41.19 - $52.25 $4.29 Million - $5.44 Million	-104,120 Reduced 34.99%	193,452 $9.78 Million
Q2 2023 Jul 27, 2023	BUY	$36.89 - $56.88 $3.47 Million - $5.35 Million	93,990 Added 46.17%	297,572 $13.9 Million
Q1 2023 May 02, 2023	BUY	$37.27 - $50.24 $7.44 Million - $10 Million	199,495 Added 4881.21%	203,582 $7.79 Million
Q4 2022 Feb 10, 2023	BUY	$33.44 - $54.8 $1,237 - $2,027	37 Added 0.91%	4,087 $223,000
Q4 2022 Feb 09, 2023	SELL	$33.44 - $54.8 $507,084 - $830,987	-15,164 Reduced 78.92%	4,050 $221,000
Q3 2022 Nov 02, 2022	SELL	$10.15 - $34.05 $7,125 - $23,903	-702 Reduced 3.52%	19,214 $654,000
Q2 2022 Aug 01, 2022	SELL	$8.0 - $15.01 $80 - $150	-10 Reduced 0.05%	19,916 $188,000
Q1 2022 May 04, 2022	BUY	$12.97 - $22.26 $9,299 - $15,960	717 Added 3.73%	19,926 $209,000
Q4 2021 Feb 07, 2022	SELL	$19.87 - $26.24 $54,900 - $72,501	-2,763 Reduced 12.58%	19,209 $406,000
Q3 2021 Nov 02, 2021	BUY	$18.65 - $25.46 $578 - $789	31 Added 0.14%	21,972 $491,000
Q2 2021 Aug 03, 2021	SELL	$24.81 - $32.35 $25,331 - $33,029	-1,021 Reduced 4.45%	21,941 $544,000
Q1 2021 May 04, 2021	SELL	$24.04 - $34.19 $25,434 - $36,173	-1,058 Reduced 4.4%	22,962 $666,000
Q4 2020 Feb 01, 2021	SELL	$25.12 - $29.89 $25,672 - $30,547	-1,022 Reduced 4.08%	24,020 $620,000
Q3 2020 Nov 09, 2020	SELL	$30.79 - $39.92 $266,826 - $345,946	-8,666 Reduced 25.71%	25,042 $771,000
Q2 2020 Aug 07, 2020	SELL	$19.25 - $26.76 $4,543 - $6,315	-236 Reduced 0.7%	33,708 $840,000
Q1 2020 May 04, 2020	BUY	$12.8 - $27.05 $413,900 - $874,688	32,336 Added 2010.95%	33,944 $720,000
Q4 2019 Feb 06, 2020	SELL	$17.37 - $27.27 $565,845 - $888,347	-32,576 Reduced 95.3%	1,608 $36,000
Q4 2019 Feb 04, 2020	BUY	$17.37 - $27.27 $548,110 - $860,504	31,555 Added 1200.27%	34,184 $844,000
Q3 2019 Nov 12, 2019	BUY	$16.89 - $29.88 $17,244 - $30,507	1,021 Added 63.5%	2,629 $60,000
Q2 2019 Aug 15, 2019	BUY	$18.08 - $19.83 $29,072 - $31,886	1,608 New	1,608 $31,000

Others Institutions Holding AKRO

# of Institutions

170

Shares Held

72.7M

Call Options Held

178K

Put Options Held

164K

Janus Henderson Group PLC London, X0

6.88M
Shares

$204 Million
0.09% of portfolio
Black Rock Inc. New York, NY

5.59M
Shares

$166 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.43M
Shares

$161 Million
2.13% of portfolio
General Atlantic LLC New York, NY

5.23M
Shares

$156 Million
3.88% of portfolio
Wellington Management Group LLP Boston, MA

5.11M
Shares

$152 Million
0.02% of portfolio

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.38B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account